Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells

COX-2 can be considered as a clinically relevant molecular target for adjuvant, in particular radiosensitizing treatments. In this regard, using selective COX-2 inhibitors, e.g., in combination with radiotherapy or endoradiotherapy, represents an interesting treatment option. Based on our own findin...

Full description

Bibliographic Details
Main Authors: Florian Brandt, Martin Ullrich, Verena Seifert, Cathleen Haase-Kohn, Susan Richter, Torsten Kniess, Jens Pietzsch, Markus Laube
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Molecules
Subjects:
cancer
endoradionuclide therapy
NO donors
pheochromocytoma
(pseudo)hypoxia
radiation therapy
Online Access:https://www.mdpi.com/1420-3049/27/19/6587

Internet

https://www.mdpi.com/1420-3049/27/19/6587

Similar Items